Discover 2.0 Customer Highlight: Dr. Lowe

Dr. Lowe leads a lab in the School of Dentistry at the University of Maryland. CEM reached out to Noha, one of her graduate students, to learn more about the wide range of research projects taking place in the group. The Lowe group owns a Discover 2.0 microwave synthesis reactor.

Q: Could you provide some background on the Lowe research group?

A: Our research group focuses on innovative bionanotechnology, drug and gene delivery, regenerative medicine, precision medicine, neural engineering, stem cell engineering, contraception, and biosensoring. The research activities include rational design and synthesis of multi-stimuli-responsive biomaterials including nanogels, branched/dendritic nanoparticles, hydrogels and thin films; characterizations of the mechanisms by which the designed biomaterials regulate targeted and sustained delivery of drugs, proteins and genes, promote cell growth, and provide biosensing; and in vitro and vivo studies of the bioefficacy of these biomaterials.

Q: How has the Discover 2.0 improved your research?

A: The Discover 2.0 microwave reactor allowed us a rapid reaction with high yields compared to conventional methods.

Q: How could the Discover 2.0 be useful for other scientists?

A: The microwave power will offer a method for faster organic or inorganic synthetic chemistry, medicinal chemistry, and nanomaterials synthesis. When pressure is adjusted it can also be useful for handling proteins.

Q: Where should scientists look for further reading on your research?

This is Dr. Lowe’s lab page in the University of Maryland’s official website. All the research and publication information should be found there.